Investor News
Detailing the news for investors with regards to Microvisk's development.
Microvisk scoops Healthcare Project of the Year Award as distributors queue up at Medica
CoagMax® and CoagLite® devices using world’s first diagnostic smart strip set for launch in 2012
Microvisk Technologies has scooped the Healthcare Project of the Year Award at the prestigious BioNoW Biomedical Awards, which showcase the leading biomedical companies in the north west of England.
The Healthcare Award comes as Microvisk marks the highly successful introduction of its handheld devices which monitor the blood clotting status of patients at Medica, the world’s leading medical trade fair which attracts over 137,000 visitors, ahead of product launches during 2012.
For more information the December Press Release is now available.
Microvisk to Exhibit in Booth 2B46 at MEDICA from 16 to 19 November
The MEDICA Congress in Dusseldorf is Germany’s largest interdisciplinary professional development forum. It is a trend-setter in the area of medical professional development.
The combination of product display and well-founded information, congresses, forums as well as expert workshops and the opportunity for a professional exchange of ideas establishes MEDICA as the leading international industry meeting point, characterized by a high level of international exposure.
MEDICA is the world leader amongst medical trade fairs and for this reason, Microvisk will be there.
Microvisk will host a large booth In Hall 2 of MEDICA, at number 2B46. Microvisk is listed in the MEDICA exhibitor manual as a manufacturer of mechanical devices and systems for coagulation analysis. Please stop by and visit our exhibit between November 16 and 19 in Duesseldorf to learn more about Microvisk and our products.
For more information on the event, please visit www.medica.de.
Microvisk introduces world’s first diagnostic smart strip system in the US - CoagMax® and CoagLite® devices set for trials in major US medical centres
Microvisk Technologies has introduced its unique handheld devices which monitor the blood clotting status of patients to the US market at the prestigious American Association for Clinical Chemistry annual conference. The Microvisk devices attracted strong interest from distributors and potential partners ahead of clinical trials in major US medical centres this autumn and product launches in 2012. Further information can be read in the August Press Release
Microvisk has continued to grow since the last fund raising round and is pleased to announce not only new Board appointments, but also a broadening of its patent portfolio. Bill Moffitt has joined as Chairman and Peter Whitehouse as CFO; both have strong backgrounds in the pharmaceutical and bring a wealth of knowledge and experience. The additional patents are for the USA and Japan and more information is contained in the recent press release.
Microvisk are very pleased to announce that they have completed a further internal funding round in December 2010 for £6m – this brings the fund raising total for 2010 to £10.5m which is believed to be the highest amount raised in 2010 in the UK for a pre revenue biotech company. For more information, the press release is now available!
Microvisk is pleased to announce that it has raised a further £2.5m in July 2010 from its current investors by way of a Rights Issue. The offer was significantly oversubscribed reflecting the shareholders confidence in the progress of the company towards a marketable product. Further information can be read in the September Fundraising Release
Microvisk Technologies is pleased to announce that during January 2010, it has raised £2m by attracting new investors and retaining support from its current private and institutional investors.
John Curtis, CEO of Microvisk, said:
"We are extremely pleased that in such a difficult capital market, the fundamental advantages of the Microvisk technology and product in development has been recognised by our new investors and that our current investors have continued to support our product development in a time when the alternative investment opportunities are so numerous."
Read the full Press Release for further information.
The development program is now focused on the completion of simple hand held instruments with disposable plastic test strips for the measurement of Prothrombin Time; both in the Doctor’s office and the home testing environments.
The 2007 funding enabled Microvisk to expand into new premises in St Asaph and Chipping Warden, providing the space and resources for future expansion and to assist the further development of the technologies and applications.
The 2006 funding enabled Microvisk to conduct a trial at St Bartholomew's Hospital Group in London with assistance from Professor John Pasi, Professor of Haemostasis and Thrombosis and the results were spectacular in regards of the performance of our prototype when compared to systems already on the market.
Microvisk was formed in 2004 as a spin out from Rutherford Appleton Laboratories with its first patent being filed in December 2003.
Press Release – 11 August 2011
Microvisk introduces World’s First Diagnostic smart strip system in the US
CoagMax® and CoagLite® devices set for trials in major US medical centres
Microvisk Technologies has introduced its unique handheld devices which monitor the blood clotting status of patients to the US market at the prestigious American Association for Clinical Chemistry annual conference. The Microvisk devices attracted strong interest from distributors and potential partners ahead of clinical trials in major US medical centres this autumn and product launches in 2012.
What's next?
Contact us for more information on 0845 956 9900 or why not make an enquiry and we'll be in touch shortly.
